REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sensible Biotechnologies S.R.O. (Slovakia)

Main Activities: Research and Development in Nanotechnology | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Sensible Biotechnologies S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sensible Biotechnologies S.R.O. is based in Slovakia. The head office is in Bratislava. The company operates in the Research and Development in Nanotechnology sector. The company was established on December 16, 2021. From the latest financial highlights, Sensible Biotechnologies S.R.O. reported a net sales revenue increase of 107.86% in 2024. Its total assets grew by 69.18% over the same period. Sensible Biotechnologies S.R.O.’s net profit margin decreased by 0.62% in 2024.

Headquarters
Svatoplukova, 30
Bratislava; Bratislavsky; Postal Code: 82108

Contact Details: Purchase the Sensible Biotechnologies S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Sensible Biotechnologies S.R.O. report to view the information.
Financial Auditors:
Purchase the Sensible Biotechnologies S.R.O. report to view the information.
Incorporation Date:
December 16, 2021
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sensible Biotechnologies S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
107.86%▲
Total operating revenue
95.73%▲
Operating profit (EBIT)
96.23%▲
EBITDA
92.78%▲
Net Profit (Loss) for the Period
75.96%▲
Total Assets
69.18%▲
Total Equity
78.89%▲
Operating Profit Margin (ROS)
-0.3%▼
Net Profit Margin
-0.62%▼
Return on Equity (ROE)
-0.23%▼
Debt/Equity
0.2%▲
Quick Ratio
-0.05%▼
Cash Ratio
-0.32%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo